para-chloroamphetamine

**para-chloroamphetamine** is a synthetic amphetamine derivative primarily used as a research tool in neuropharmacology. It acts as a potent **serotonin–norepinephrine–dopamine releasing agent (SNDRA)**, causing the release and subsequent depletion of serotonin (and to a lesser extent dopamine and norepinephrine) in the central nervous system[1][3]. At low doses, it exhibits serotonergic effects, but in higher doses, it is a selective serotonergic neurotoxin, capable of long-lasting depletion of brain serotonin by destroying serotonergic neurons[1][3][7]. It has been studied preclinically as a neurotoxin and, historically, was considered as a potential appetite suppressant and antidepressant, but was not marketed due to pronounced neurotoxicity seen in animal studies[1]. It is mainly used experimentally to study the function of serotonergic systems and mechanisms underlying neurotoxicity[1][3][7]. In addition to its effects on monoamine release, para-chloroamphetamine has been shown to inhibit the Arg/N-end rule pathway (regulating protein degradation), leading to stabilization of proteins such as RGS4 in neural tissues[5].

Other names

para-ChloroamphetaminePCA4-chloroamphetamine4-CAp-chloroamphetaminep-chloramphetamine(1S)-2-(4-chlorophenyl)-1-methylethylamine1-(4-chlorophenyl)propan-2-amine